Gulf Pharmaceutical Industries P.S.C.

ADX:JULPHAR Stock Report

Market Cap: د.إ1.6b

Gulf Pharmaceutical Industries P.S.C Balance Sheet Health

Financial Health criteria checks 5/6

Gulf Pharmaceutical Industries P.S.C has a total shareholder equity of AED948.7M and total debt of AED529.9M, which brings its debt-to-equity ratio to 55.9%. Its total assets and total liabilities are AED2.0B and AED1.1B respectively. Gulf Pharmaceutical Industries P.S.C's EBIT is AED80.8M making its interest coverage ratio 1.4. It has cash and short-term investments of AED483.9M.

Key information

55.86%

Debt to equity ratio

د.إ529.90m

Debt

Interest coverage ratio1.4x
Cashد.إ483.90m
Equityد.إ948.70m
Total liabilitiesد.إ1.08b
Total assetsد.إ2.03b

Recent financial health updates

No updates

Recent updates

Gulf Pharmaceutical Industries P.S.C. (ADX:JULPHAR) Screens Well But There Might Be A Catch

Apr 28
Gulf Pharmaceutical Industries P.S.C. (ADX:JULPHAR) Screens Well But There Might Be A Catch

Statutory Profit Doesn't Reflect How Good Gulf Pharmaceutical Industries P.S.C's (ADX:JULPHAR) Earnings Are

Mar 25
Statutory Profit Doesn't Reflect How Good Gulf Pharmaceutical Industries P.S.C's (ADX:JULPHAR) Earnings Are

Improved Revenues Required Before Gulf Pharmaceutical Industries P.S.C. (ADX:JULPHAR) Stock's 26% Jump Looks Justified

Oct 16
Improved Revenues Required Before Gulf Pharmaceutical Industries P.S.C. (ADX:JULPHAR) Stock's 26% Jump Looks Justified

Gulf Pharmaceutical Industries P.S.C.'s (ADX:JULPHAR) Share Price Boosted 42% But Its Business Prospects Need A Lift Too

Jan 15
Gulf Pharmaceutical Industries P.S.C.'s (ADX:JULPHAR) Share Price Boosted 42% But Its Business Prospects Need A Lift Too

Gulf Pharmaceutical Industries P.S.C.'s (ADX:JULPHAR) Price Is Right But Growth Is Lacking

Nov 04
Gulf Pharmaceutical Industries P.S.C.'s (ADX:JULPHAR) Price Is Right But Growth Is Lacking

Gulf Pharmaceutical Industries P.S.C's (ADX:JULPHAR) Solid Profits Have Weak Fundamentals

Mar 26
Gulf Pharmaceutical Industries P.S.C's (ADX:JULPHAR) Solid Profits Have Weak Fundamentals

Gulf Pharmaceutical Industries P.S.C's(ADX:JULPHAR) Share Price Is Down 59% Over The Past Five Years.

Feb 08
Gulf Pharmaceutical Industries P.S.C's(ADX:JULPHAR) Share Price Is Down 59% Over The Past Five Years.

Here's What Gulf Pharmaceutical Industries P.S.C.'s (ADX:JULPHAR) Shareholder Ownership Structure Looks Like

Dec 14
Here's What Gulf Pharmaceutical Industries P.S.C.'s (ADX:JULPHAR) Shareholder Ownership Structure Looks Like

Financial Position Analysis

Short Term Liabilities: JULPHAR's short term assets (AED1.6B) exceed its short term liabilities (AED529.1M).

Long Term Liabilities: JULPHAR's short term assets (AED1.6B) exceed its long term liabilities (AED553.6M).

Debt to Equity History and Analysis

Debt Level: JULPHAR's net debt to equity ratio (4.8%) is considered satisfactory.

Reducing Debt: JULPHAR's debt to equity ratio has reduced from 117% to 55.9% over the past 5 years.

Debt Coverage: JULPHAR's debt is well covered by operating cash flow (31.1%).

Interest Coverage: JULPHAR's interest payments on its debt are not well covered by EBIT (1.4x coverage).

Balance Sheet

Discover healthy companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/16 18:30
End of Day Share Price 2025/05/16 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Gulf Pharmaceutical Industries P.S.C. is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Rim Ben Salah GharbiAlphaMena
null RESEARCH DEPARTMENTPrime Research